CD19 (CD19 molecule)

2003-11-01  

Identity

HGNC
LOCATION
16p11.2
LOCUSID
ALIAS
B4,CVID3
FUSION GENES

Other Information

Locus ID:

NCBI: 930
MIM: 107265
HGNC: 1633
Ensembl: ENSG00000177455

Variants:

dbSNP: 930
ClinVar: 930
TCGA: ENSG00000177455
COSMIC: CD19

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000177455ENST00000324662P15391
ENSG00000177455ENST00000538922P15391

Expression (GTEx)

0
50
100
150
200

Pathways

PathwaySourceExternal ID
Hematopoietic cell lineageKEGGko04640
B cell receptor signaling pathwayKEGGko04662
Primary immunodeficiencyKEGGko05340
Hematopoietic cell lineageKEGGhsa04640
B cell receptor signaling pathwayKEGGhsa04662
Primary immunodeficiencyKEGGhsa05340
Epstein-Barr virus infectionKEGGhsa05169
Epstein-Barr virus infectionKEGGko05169
PI3K-Akt signaling pathwayKEGGhsa04151
PI3K-Akt signaling pathwayKEGGko04151
DiseaseREACTOMER-HSA-1643685
Diseases of signal transductionREACTOMER-HSA-5663202
PI3K/AKT Signaling in CancerREACTOMER-HSA-2219528
Constitutive Signaling by Aberrant PI3K in CancerREACTOMER-HSA-2219530
Immune SystemREACTOMER-HSA-168256
Adaptive Immune SystemREACTOMER-HSA-1280218
Signaling by the B Cell Receptor (BCR)REACTOMER-HSA-983705
Antigen activates B Cell Receptor (BCR) leading to generation of second messengersREACTOMER-HSA-983695
Downstream signaling events of B Cell Receptor (BCR)REACTOMER-HSA-1168372
PIP3 activates AKT signalingREACTOMER-HSA-1257604
Negative regulation of the PI3K/AKT networkREACTOMER-HSA-199418
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cellREACTOMER-HSA-198933
Innate Immune SystemREACTOMER-HSA-168249
DAP12 interactionsREACTOMER-HSA-2172127
DAP12 signalingREACTOMER-HSA-2424491
Fc epsilon receptor (FCERI) signalingREACTOMER-HSA-2454202
Role of LAT2/NTAL/LAB on calcium mobilizationREACTOMER-HSA-2730905
Signal TransductionREACTOMER-HSA-162582
Signaling by EGFRREACTOMER-HSA-177929
GAB1 signalosomeREACTOMER-HSA-180292
Signalling by NGFREACTOMER-HSA-166520
NGF signalling via TRKA from the plasma membraneREACTOMER-HSA-187037
PI3K/AKT activationREACTOMER-HSA-198203
Signaling by PDGFREACTOMER-HSA-186797
Downstream signal transductionREACTOMER-HSA-186763
Signaling by SCF-KITREACTOMER-HSA-1433557
PI5P, PP2A and IER3 Regulate PI3K/AKT SignalingREACTOMER-HSA-6811558

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
374979992024Novel chimeric antigen receptor targets and constructs for acute lymphoblastic leukemia: Moving beyond CD19.0
378706812024Tumor-derived exosomes induce initial activation by exosomal CD19 antigen but impair the function of CD19-specific CAR T-cells via TGF-β signaling.0
380953182024Evaluation of transcription factors and cytokine expressions of T-cell subsets in CD19 deficiency and their possible relationship with autoimmune disease.0
383769442024Immunotherapy-resistant acute lymphoblastic leukemia cells exhibit reduced CD19 and CD22 expression and BTK pathway dependency.1
374979992024Novel chimeric antigen receptor targets and constructs for acute lymphoblastic leukemia: Moving beyond CD19.0
378706812024Tumor-derived exosomes induce initial activation by exosomal CD19 antigen but impair the function of CD19-specific CAR T-cells via TGF-β signaling.0
380953182024Evaluation of transcription factors and cytokine expressions of T-cell subsets in CD19 deficiency and their possible relationship with autoimmune disease.0
383769442024Immunotherapy-resistant acute lymphoblastic leukemia cells exhibit reduced CD19 and CD22 expression and BTK pathway dependency.1
357530012023Host B cells escape CAR-T immunotherapy by reversible downregulation of CD19.4
364690242023Compromised antigen binding and signaling interfere with bispecific CD19 and CD79a chimeric antigen receptor function.4
366032922023CD19+ B cell values predict the increase of anti-SARS CoV2 antibodies in fingolimod-treated and COVID-19-vaccinated patients with multiple sclerosis.5
374078402023Transcriptional signatures associated with persisting CD19 CAR-T cells in children with leukemia.12
357530012023Host B cells escape CAR-T immunotherapy by reversible downregulation of CD19.4
364690242023Compromised antigen binding and signaling interfere with bispecific CD19 and CD79a chimeric antigen receptor function.4
366032922023CD19+ B cell values predict the increase of anti-SARS CoV2 antibodies in fingolimod-treated and COVID-19-vaccinated patients with multiple sclerosis.5

Citation

Dessen P

CD19 (CD19 molecule)

Atlas Genet Cytogenet Oncol Haematol. 2003-11-01

Online version: http://atlasgeneticsoncology.org/gene/969/cd19-(cd19-molecule)